Skip to content

Effect of misoprostol on labor

A comparison of vaginal misoprostol tablet and oxytocin in induction of labor at term pregnancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201202018897N1
Enrollment
102
Registered
2012-03-07
Start date
2008-12-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Efficacy on induction of labor. Failed medical induction of labour

Interventions

Insertion of 100 microgram vaginal misoprostol.
Treatment - Drugs
Insertion of 100 microgram vaginal misoprostol

Sponsors

Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: singleton live pregnancy at term(GA= 37week) in the cephalic presentation; absent of active labor; unfavorable cervix(Bishop scor=6) and normal fetal heart rate tracing. Exclusion criteria: known cephalopelvic disproportion; abnormal presentation; previous cesarean delivery or other type of uterine surgery; cervical cancer; fetal macrosomia; active herpes genitalia; multiparity and fetal anomaly.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Interval from induction to true labor. Timepoint: Vaginal exam for evaluation of dilatation and effacment. Method of measurement: By vaginal exam.;Interval from true labor to delivery. Timepoint: Vaginal exam for evaluation of dilatation and effacment q 1 hour. Method of measurement: By vaginal exam.;Interval from induction to delivery. Timepoint: Vaginal exam for evaluation of dilatation and effacment q 1 hour. Method of measurement: By vaginal exam.

Secondary

MeasureTime frame
Rate of vaginal delivery. Timepoint: At delivery time and 48 hours afterthat. Method of measurement: By clinical evaluation and add to form.;Post partum complication. Timepoint: At delivery time and 48 hours afterthat. Method of measurement: By clinical evaluation and add to form.;Neonatal outcom. Timepoint: At delivery time and 48 hours afterthat. Method of measurement: By clinical evaluation and add to form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Rouholamin safoura

Faculty of medicin

s _rouholamin@med.mui.ac.ir+98 31123670015

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026